Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression.
JHEP Rep. 2022 Oct 13;5(1):100604. doi: 10.1016/j.jhepr.2022.100604. eCollection 2023 Jan.
JHEP Rep. 2022.
PMID: 36440258
Free PMC article.
EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
Leung HW, Leung CON, Lau EY, Chung KPS, Mok EH, Lei MML, Leung RWH, Tong M, Keng VW, Ma C, Zhao Q, Ng IOL, Ma S, Lee TK.
Leung HW, et al. Among authors: leung rwh.
Cancer Res. 2021 Jun 15;81(12):3229-3240. doi: 10.1158/0008-5472.CAN-21-0184. Epub 2021 Apr 26.
Cancer Res. 2021.
PMID: 33903122
Item in Clipboard
Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells.
Chung KPS, Leung RWH, Lee TKW.
Chung KPS, et al. Among authors: leung rwh.
Cancers (Basel). 2021 Jun 25;13(13):3191. doi: 10.3390/cancers13133191.
Cancers (Basel). 2021.
PMID: 34202411
Free PMC article.
Review.
Item in Clipboard
UBE2T: A new molecular regulator of cancer stemness in hepatocellular carcinoma.
Leung RWH, Ho NPY, Leung CON, Lee TKW.
Leung RWH, et al.
Oncotarget. 2021 Aug 17;12(17):1727-1728. doi: 10.18632/oncotarget.28033. eCollection 2021 Aug 17.
Oncotarget. 2021.
PMID: 34434501
Free PMC article.
No abstract available.
Item in Clipboard
Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma.
Leung RWH, Lee TKW.
Leung RWH, et al.
Cancers (Basel). 2022 Nov 7;14(21):5468. doi: 10.3390/cancers14215468.
Cancers (Basel). 2022.
PMID: 36358885
Free PMC article.
Review.
Item in Clipboard
Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma.
Leung CON, Yang Y, Leung RWH, So KKH, Guo HJ, Lei MML, Muliawan GK, Gao Y, Yu QQ, Yun JP, Ma S, Zhao Q, Lee TKW.
Leung CON, et al. Among authors: leung rwh.
Nat Commun. 2023 Oct 23;14(1):6699. doi: 10.1038/s41467-023-42360-w.
Nat Commun. 2023.
PMID: 37872167
Free PMC article.
Item in Clipboard
Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer.
Xie Y, Wu H, He Y, Liu L, Huang IB, Zhou L, Lin CY, Leung RW, Loh JJ, Lee TK, Ding J, Man K, Ma S, Tong M.
Xie Y, et al.
Cell Death Dis. 2024 Feb 3;15(2):110. doi: 10.1038/s41419-024-06493-0.
Cell Death Dis. 2024.
PMID: 38310091
Free PMC article.
Item in Clipboard
Cite
Cite